as on January 29, 2026 at 2:23 pm IST
Day's Low
Day's High
1.71%
Downside
5.76%
Upside
52 Week's Low
52 Week's High
46.85%
Downside
35.15%
Upside
as on January 29, 2026 at 2:23 pm IST
Market Cap
₹392.89 Cr
Return on Equity (ROE)
-2.23
PE Ratio (TTM)
0Return on capital employed (ROCE)
1.72
Beta (LTM)
0.33
P/B Ratio
3.55
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
56.76
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Everest Organics with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 392.89 | 12.49% | 0.00 | -2 | 159 | |
| NA | 342.36 | 39.46% | 0.69 | 7 | 155 | |
| NA | 267.78 | 30.7% | 0.64 | 7 | 138 | |
| NA | 8,866.99 | 0.16% | 0.59 | 149 | 1,196 | |
| NA | 20.35 | 19.63% | 0.00 | NA | 15 |
Get share price movements and forecasts by analysts on Everest Organics.
Source: S&P Global Market Intelligence
Search interest for Everest Organics Ltd Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:39% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Everest Organics.
Everest Organics Ltd’s net profit jumped 56.76% since last year same period to ₹1.16Cr in the Q2 2025-2026. On a quarterly growth basis, Everest Organics Ltd has generated -17.73% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2022, Everest Organics Ltd has declared dividend of ₹0.50 per share on 27 May 2022 - translating a dividend yield of 0.37%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, Everest Organics has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 1 Year
![]()
In the last 1 year, Everest Organics has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Up
![]()
Retail Investor have increased holdings from 40.33% to 40.37% in Dec 2025 quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 59.64% to 59.61% in Dec 2025 quarter
Price Dip
![]()
In the last 1 month, Everest Organics stock has moved down by -19.5%
| Organisation | Everest Organics Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | K. Ramakrishnam Raju |
| E-voting on shares | Click here to vote |
Everest Organics share price today stands at ₹396.9 as on . Everest Organics share today touched a day high of ₹419.75 and a low of ₹390.1.
Everest Organics touched a 52 week high of ₹536.4 and a 52 week low of ₹210.95. Everest Organics share price today i.e. is trending at ₹396.9, which is -26.01% down from its 52 week high and 88.15% up from its 52 week low.
Everest Organics market capitalisation is ₹392.89 Cr as on .
To buy Everest Organics shares, you need to follow these steps:
Everest Organics trading volume is 293.00 as on . This means that 293.00 shares of Everest Organics were bought and sold on the stock market during today's trading session.